Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Kyle A. Serikawa, Søren Jacobsen, Dorthe Lundsgaard, Brian A. Fox, Lone Hummelshoj, Lars K. Poulsen, Jan Fleckner & Klaus Stensgaard Frederiksen. (2013) Detection of gene expression signatures related to underlying disease and treatment in rheumatoid arthritis patients. Modern Rheumatology 23:4, pages 729-740.
Read now
Read now
Articles from other publishers (12)
Antonella Farina, Edoardo Rosato, Michael York, Benjamin E. Gewurz, Maria Trojanowska & Giuseppina Alessandra Farina. (2021) Innate Immune Modulation Induced by EBV Lytic Infection Promotes Endothelial Cell Inflammation and Vascular Injury in Scleroderma. Frontiers in Immunology 12.
Crossref
Crossref
George N. Goulielmos, Maria I. Zervou, Vassilis M. Vazgiourakis, Yogita Ghodke-Puranik, Alexandros Garyfallos & Timothy B. Niewold. (2018) The genetics and molecular pathogenesis of systemic lupus erythematosus (SLE) in populations of different ancestry. Gene 668, pages 59-72.
Crossref
Crossref
Cécile Picard & Alexandre Belot. (2017) Does type-I interferon drive systemic autoimmunity?. Autoimmunity Reviews 16:9, pages 897-902.
Crossref
Crossref
K C Kalunian. (2016) Interferon-targeted therapy in systemic lupus erythematosus: Is this an alternative to targeting B and T cells?. Lupus 25:10, pages 1097-1101.
Crossref
Crossref
Maria Teruel & Marta E. Alarcón-Riquelme. (2016) Genetics of systemic lupus erythematosus and Sjögren's syndrome: an update. Current Opinion in Rheumatology 28:5, pages 506-514.
Crossref
Crossref
Kenneth C Kalunian, Joan T Merrill, Romeo Maciuca, Jacqueline M McBride, Michael J Townsend, Xiaohui Wei, John C DavisJrJr & William P Kennedy. (2016) A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE). Annals of the Rheumatic Diseases 75:1, pages 196-202.
Crossref
Crossref
Laurent Chiche, Noémie Jourde-Chiche, Elizabeth Whalen, Scott Presnell, Vivian Gersuk, Kristen Dang, Esperanza Anguiano, Charlie Quinn, Stéphane Burtey, Yvon Berland, Gilles Kaplanski, Jean-Robert Harle, Virginia Pascual & Damien Chaussabel. (2014) Modular Transcriptional Repertoire Analyses of Adults With Systemic Lupus Erythematosus Reveal Distinct Type I and Type II Interferon Signatures. Arthritis & Rheumatology 66:6, pages 1583-1595.
Crossref
Crossref
A Becker-Merok, G Østli-Eilersten, S Lester & JC Nossent. (2012) Circulating interferon-α2 levels are increased in the majority of patients with systemic lupus erythematosus and are associated with disease activity and multiple cytokine activation. Lupus 22:2, pages 155-163.
Crossref
Crossref
Lionel B. Ivashkiv. 2012. Jak-Stat Signaling : From Basics to Disease. Jak-Stat Signaling : From Basics to Disease
353
370
.
Xiaoyu Hu, Soumya D. Chakravarty & Lionel B. Ivashkiv. (2008) Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunological Reviews 226:1, pages 41-56.
Crossref
Crossref
Hong Wang, Minliang Zhou, Joseph Brand & Liquan Huang. (2007) Inflammation Activates the Interferon Signaling Pathways in Taste Bud Cells. The Journal of Neuroscience 27:40, pages 10703-10713.
Crossref
Crossref
Xiaoping Qing & Chaim Putterman. (2004) Gene expression profiling in the study of the pathogenesis of systemic lupus erythematosus. Autoimmunity Reviews 3:7-8, pages 505-509.
Crossref
Crossref